Exhibit 99.1

 

September 26, 2024

Filed via SEDAR+

To All Applicable Exchanges and Securities Administrators

Subject:	InMed Pharmaceuticals Inc. (the “Issuer”)
	Notice of Meeting and Record Date

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer’s upcoming meeting of securityholders:

Meeting Type:	Annual General Meeting
Meeting Date:	December 18, 2024
Record Date for Notice of Meeting:	October 21, 2024
Record Date for Voting (if applicable):	October 21, 2024
Beneficial Ownership Determination Date:	October 21, 2024
Class of Securities Entitled to Vote:	Common Shares
ISIN:	CA4576376012
Issuer sending proxy materials directly to NOBOs:	No
Issuer paying for delivery to OBOs:	No
Notice and Access for Beneficial Holders:	Yes
Notice and Access for Registered Holders:	Yes

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

Odyssey Trust Company

as agent for InMed Pharmaceuticals Inc.